Production AI for PE Firms and their Life Sciences Portfolio Companies
CapeStart turns document-heavy workflows and fragmented knowledge bases at PE-backed life sciences companies into production AI: Document Intelligence and Conversational Search. A four-week working prototype proves the value on your data, then a scoped path to production, powered by auditable, explainable AI built for regulated life sciences, a value-creation lever that moves EBITDA and product differentiation.
Trusted by leading sponsors
Trusted by PE Sponsors and Their PortCos
From growth-stage to buyout, leading sponsors rely on CapeStart to deliver AI capability across their portfolios.
The Life Sciences Delivery Record Behind the Value-Creation Work
Selected client experience across healthcare & life sciences. References available on request.
Where AI earns its place in the deal
AI Underwritten to the Thesis, Not Run as an Experiment
On most PE-backed life sciences companies, AI sits in the value-creation plan and never reaches production before exit. CapeStart ties it directly to the three things the deal is priced on — top-line growth, margin, and defensibility — and ships capability that shows up in the numbers, not in a pilot deck.
Top-line growth
For PortCos carrying a growth mandate, we build AI into the product itself — new data-driven features, faster roadmap velocity, and the kind of differentiation a strategic acquirer pays a premium for.
Margin expansion
When the plan calls for margin, we automate the document-heavy, expert-time workflows that quietly cap EBITDA — clinical, regulatory, quality, and claims review — so output rises without adding headcount.
An exit-ready AI story
AI is now a diligence question. We deliver auditable, explainable capability a buyer can verify — not slideware — so the AI line in the value-creation plan stands up at exit.
The same productized build serves both sides of the table: an AI workstream operating partners and sponsors can underwrite, and operating leverage the PortCo executive team can run — one repeatable motion across the portfolio.
How we build the capability
Two Productized AI Builds Do Most of the Value-Creation Work
Not a platform to license or a pilot to run. Two scoped engineering builds, delivered by CapeStart’s team into the PortCo — the mechanism behind the revenue and margin outcomes above.
Document Intelligence
Turn unstructured documents into structured, queryable data.
Life sciences PortCos sit on mountains of unstructured documents: clinical files, regulatory submissions, device documentation, contracts, claims, scientific literature. CapeStart builds a capability that extracts, classifies, and structures that content at scale — roughly 70% already built and reused across clients.
- OCR, NLP and document classification, production standard
- Structured fields extracted from unstructured sources
- Integrated via API into the product or workflow
- Tuned for regulated, high-accuracy life sciences data
On a systematic literature-review build, CapeStart cut review time by 60%, unifying library, medical-writing, and clinical teams on one platform for search, screening, extraction, and report generation.
Conversational Search
Let people ask your data questions in natural language.
People and customers shouldn't need to know where information lives or how to query it. CapeStart builds a natural-language interface over the company's content and data, grounded in its sources — roughly 70% already built and reused across clients — so answers are accurate, cited, and trustworthy enough for a regulated setting.
- RAG-based search grounded in the company's own data
- Cited, source-backed answers that reduce hallucination risk
- Integrated into the product or internal tools via API
- Tuned for the precision life sciences users require
A conversational media-intelligence assistant returned insights in seconds and scaled across millions of documents. Fragmented access became instant, cited answers — driving retention and stickiness.
Three Things That Rarely Live Under One Roof
Advisory shops hand you a deck. Platform vendors hand you a license. Offshore teams hand you capacity. CapeStart is the blend of all three — and that’s the differentiation.
Proven, largely pre-built assets
Roughly 70% of each build already exists and is reused across clients — engagements start from a working asset, not a blank page.
Product-grade life sciences engineering
60+ AI/ML implementations across life sciences, healthcare, and pharma, with 90%+ proven model accuracy.
Compliance built for diligence
HIPAA, SOC 2 Type 2, and GDPR validated in your environment — evidence ready before a buyer’s diligence asks.
Proven, Largely Pre-built Assets
Roughly 70% of each build already exists and is reused across clients — engagements start from a working asset, not a blank page.
Product-grade Life Sciences Engineering
60+ AI/ML implementations across life sciences, healthcare, and pharma, with 90%+ proven model accuracy.
Compliance Built For Diligence
HIPAA, SOC 2 Type 2, and GDPR validated in your environment — evidence ready before a buyer’s diligence asks.
-
From value-creation plan to exit
A roadmap engineered around outcomes — not experiments.
-
Proven on your data in 4 weeks
Working results on real workloads — measured, not promised.
-
Built compliant for regulated life sciences
Governance, audit trails and validation from day one.
Measured, not promised
A Track Record in Regulated Life Sciences, Not a Pitch
60+
6 of 15
90%+
4 wks
70%
~2 mo
60+
AI/ML implementations in life sciences, healthcare & pharma
6/15
Top-15 life sciences companies served
90%+
Proven model accuracy on production builds
4 Wks
Proven model accuracy on production builds
70%
Of each build already exists as reusable IP
~2 mo
Typical path from prototype to production
How a rollout works across a portfolio
A Four-Phase Playbook for Scaling AI Across PortCos
One four-phase play: prove it on a single portfolio company, then run the same sequence across the rest of the book.
Map where AI moves value
We start from the value-creation plan: where regulated documents and expert time concentrate, and which workflow most directly touches revenue or margin.
Phase 01
Prove it in four weeks
Most of the capability is already built. We customize a proven asset to your data and ship a working prototype — more than a demo — that proves measurable value before production spend.
Phase 02
Take it to production
We integrate your data sources, tune for edge cases, and harden the build to HIPAA and SOC 2 Type 2 in your environment — typically a couple of months to production.
Phase 03
Scale across PortCos
The same sequence repeats across the book — lining up the next use case and the next company on a documented play, whatever maturity each PortCo starts from.
Phase 04
Map where AI moves value
We start from the value-creation plan: where regulated documents and expert time concentrate, and which workflow most directly touches revenue or margin.
Phase 01
Prove it in four weeks
Most of the capability is already built. We customize a proven asset to your data and ship a working prototype — more than a demo — that proves measurable value before production spend.
Phase 02
Take it to production
We integrate your data sources, tune for edge cases, and harden the build to HIPAA and SOC 2 Type 2 in your environment — typically a couple of months to production.
Phase 03
Scale across PortCos
The same sequence repeats across the book — lining up the next use case and the next company on a documented play, whatever maturity each PortCo starts from.
Phase 04
Optional : Forward Deployed AI Engineers Embedded with Your PortCo Team
Proven, largely pre-built assets
Roughly 70% of each build already exists and is reused across clients — engagements start from a working asset, not a blank page.
Product-grade life sciences engineering
60+ AI/ML implementations across life sciences, healthcare, and pharma, with 90%+ proven model accuracy.
Compliance built for diligence
HIPAA, SOC 2 Type 2, and GDPR validated in your environment — evidence ready before a buyer’s diligence asks.
Compliance built for diligence
HIPAA, SOC 2 Type 2, and GDPR validated in your environment — evidence ready before a buyer’s diligence asks.
Recognized for Innovation and Impact
One Question Decides Fit: How Much Regulated Content Is Buried?
Not a platform to license or a pilot to run. Two scoped engineering builds, delivered by CapeStart’s team into the PortCo — the mechanism behind the revenue and margin outcomes above.
Document Intelligence fits if
The company holds a large estate of SOPs, protocols, regulatory submissions, validation, or claims documents across PDFs and SharePoint — and an RA, Quality, Medical Affairs, PV, or CMC team that loses hours finding answers in it.
Conversational Search fits if
The company’s knowledge is spread across the systems life sciences runs on — Veeva Vault, SharePoint, regulatory and labeling archives, QMS and SOP repositories, Medical Affairs and medical-information libraries, and clinical trial files — with multi-step expert questions answered by hand, and users who want answers where they already work.
FAQs About AI Value Creation With CapeStart.
Why should a sponsor care, not just the PortCo?
How quickly does a single PortCo see a result?
A working prototype that proves value on the PortCo’s own data in four weeks. Because roughly 70% of each build is already built and reused across clients, we start from a working asset rather than a blank page — then move to production in roughly a couple of months.
Does the same approach hold up across PortCos at different stages?
Yes. The same two productized builds and four-phase motion repeat across the portfolio on a playbook, tailored to each company’s data and starting maturity — so the second and third portco move faster than the first.
What if the PortCo already has engineers?
We complement them. CapeStart carries the specialized AI build — the document and retrieval engineering, the compliance hardening, the model accuracy — so the existing team keeps its roadmap and the AI workstream doesn’t compete for capacity.
How does this stay compliant in a regulated setting?
Compliance is designed in, not bolted on: SOC 2 Type 2 validated controls, HIPAA-standard PHI handling and GDPR — validated in your environment. Answers are source-backed and auditable to reduce hallucination risk in regulated settings.
How does the deal team track progress between board meetings?
The engagement is structured around a defined starting point, a four-week proof artifact, and a scoped path to production with measurable milestones — so the AI line in the value-creation plan has a clear status at every board cycle.
Start With One PortCo, Then Scale
Start with a 30-minute working session. We’ll help map one PortCo use case from value opportunity to rollout plan.
Talk to Our Experts
Tell us what you’re trying to achieve, and we’ll get back to you.